Carr Liver Cancer in the Middle East

1. Auflage 2021
ISBN: 978-3-030-78737-0
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 414 Seiten

Reihe: Medicine

This book aims to illuminate the causes, incidence, and treatments of Hepatocellular Carcinoma(HCC) or liver cancer in the politically important and societally diverse region of the Middle East. Taking a flexible and inclusive view, it examines the influences of geography, crops and diet, ethnicity, and local behavior on both diagnosis and outcomes of this disease. Understanding the different causes of liver cancer enables effective strategies for both prevention and early diagnosis while knowledge of the different treatment modalities, their uses and limitations, availability and costs, works to inform rational treatment provision and selection. Divided into four sections, this book considers the causes and clinical syndromes associated with HCC, provides a detailed overview of clinical HCC and treatment modalities, describes country-specific clinical HCC experience and practice, and considers future needs and the potential for HCC collaborations across the region.

Liver Cancer in the Middle East is a useful resource for clinicians seeking insight into the second highest cause of death from cancer worldwide, governments planning social and medical services for their peoples, as well as for international aid agencies prioritizing donations.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Carr, Brian I.

Inhaltsverzeichnis

Biological Aspects of HCC.- Changing Etiology and Epidemiology of Human Liver Cancer.- Hepatocarcinogenesis Induced by Environmental.- Exposures in the Middle East.- Obesity and Hepatocellular Carcinoma : Epidemiology and Mechanisms.- Epidemiology of Hepatitis B Virus in the Middle East.- Hepatocellular Carcinoma in the United Arab Emirates.- Overview of Clinical HCC and its Management.- Cost Effective.- Therapies for HCC: Resection and Ablation.- Transarterial Radioembolization in Hepatocellular Carcinoma.- Intra-arterial Chemotherapy and.- Transarterial Chemoembolization in Hepatocellular Carcinoma.- Radiotherapy for Hepatocellular Carcinoma.- Liver Transplantation in Middle East.- Individual Patient Assessment and Therapy Decision-Making in a Live Donor-Based Liver Transplant Institute.- Hepatocellular Cancer in Iran.- Hepatocellular Carcinoma In Kuwait.- Insights on Hepatocellular carcinoma in Saudi Arabia.- Hepatitis C induced Hepatocellular Carcinoma in the Middle East.- Hepatocellular Carcinoma in the Middle East: An Overview.- Current HCC Clinical and Research in Egypt.- Hepatocellular Carcinoma in Turkey - A Review of Disease Epidemiology and Treatment Outcomes.- Targeting c-Met and AXL Crosstalk for the Treatment of Hepatocellular Carcinoma.- Hepatocellular Carcinoma in Morocco.- Hepatocellular Carcinoma in Lebanon and its Association with Thalassemia.- An Overview of Hepatocellular Carcinoma (HCC) in Lebanon: a focus on hepatitis B and thalassemia-related HCC.- Hepatocellular Carcinoma in Pakistan: An Update.- Future Directions.- The Need for Region-Wide HCC Collaborations.

Über Autor(innen)

Brian I. Carr 

Professor, Team Leader in Translational HCC Research

Liver Transplantation Institute

Inonu University, Malatya

Turkey